193 related articles for article (PubMed ID: 3089949)
21. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of two lithium carbonate formulations.
Foster TS; Crass RE; Bustrack JA; Smith RB; Munson JW
Am J Hosp Pharm; 1980 Nov; 37(11):1528-31. PubMed ID: 7211858
[TBL] [Abstract][Full Text] [Related]
23. Suprofen sustained release kinetics in healthy male volunteers. 1st communication: a single dose open crossover bioavailability study of suprofen sustained release tablets versus capsules.
Michos N; Zulliger HW; Barkworth MF; Johnson KJ; Rehm KD; Töberich H; Klein G
Arzneimittelforschung; 1986 Jun; 36(6):941-8. PubMed ID: 3741528
[TBL] [Abstract][Full Text] [Related]
24. Accuracy and safety of a priori lithium loading.
Kook KA; Stimmel GL; Wilkins JN; Spangher GG
J Clin Psychiatry; 1985 Feb; 46(2):49-51. PubMed ID: 3918024
[TBL] [Abstract][Full Text] [Related]
25. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.
Caldwell HC; Westlake WJ; Connor SM; Flanagan T
J Clin Pharmacol New Drugs; 1971; 11(5):349-56. PubMed ID: 5208514
[No Abstract] [Full Text] [Related]
26. [The pharmacokinetics and bioequivalence of various dosage forms of ambroxol].
Vergin H; Bishop-Freudling GB; Miczka M; Nitsche V; Strobel K; Matzkies F
Arzneimittelforschung; 1985; 35(10):1591-5. PubMed ID: 4074420
[TBL] [Abstract][Full Text] [Related]
27. Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method.
Marr MA; Djuric PE; Ritschel WA; Garver DL
Clin Pharm; 1983; 2(3):243-8. PubMed ID: 6411413
[TBL] [Abstract][Full Text] [Related]
28. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of valproic acid obtained after administration of three oral formulations to humans.
Bialer M; Hussein Z; Dubrovsky J; Raz I; Abramsky O
Isr J Med Sci; 1984 Jan; 20(1):46-9. PubMed ID: 6421770
[TBL] [Abstract][Full Text] [Related]
30. Aspect of the pharmacokinetics of slow-release lithium carbonate.
Hart GA
S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
[TBL] [Abstract][Full Text] [Related]
31. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic properties of a new sustained-release theophylline preparation.
Dahlqvist R; Billing B
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
Bareggi SR; Gambaro V; Valenti M; Benvenuti C
Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and bioavailability of a controlled release amoxicillin formulation.
Arancibia A; González G; Icarte A; Arancibia M; Arancibia P
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):97-100. PubMed ID: 3557736
[TBL] [Abstract][Full Text] [Related]
38. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
39. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacokinetics of lithium in rats of various ages].
Kersten L
Acta Biol Med Ger; 1979; 38(9):1331-45. PubMed ID: 550669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
